Innovation Pharmaceuticals Inc (IPIX)
0.0015
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Innovation Pharmaceuticals Total Liabilities (Quarterly): 5.505M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 5.505M |
June 30, 2023 | 5.478M |
March 31, 2023 | 5.277M |
December 31, 2022 | 5.61M |
September 30, 2022 | 5.917M |
June 30, 2022 | 5.649M |
March 31, 2022 | 5.843M |
December 31, 2021 | 6.123M |
September 30, 2021 | 6.433M |
June 30, 2021 | 6.79M |
March 31, 2021 | 6.719M |
December 31, 2020 | 8.972M |
September 30, 2020 | 7.022M |
June 30, 2020 | 7.786M |
March 31, 2020 | 8.48M |
December 31, 2019 | 9.112M |
September 30, 2019 | 8.859M |
June 30, 2019 | 8.175M |
March 31, 2019 | 8.293M |
December 31, 2018 | 8.643M |
September 30, 2018 | 8.277M |
June 30, 2018 | 8.692M |
March 31, 2018 | 9.467M |
December 31, 2017 | 10.62M |
September 30, 2017 | 10.83M |
Date | Value |
---|---|
June 30, 2017 | 10.58M |
March 31, 2017 | 9.329M |
December 31, 2016 | 8.656M |
September 30, 2016 | 8.773M |
June 30, 2016 | 8.481M |
March 31, 2016 | 8.429M |
December 31, 2015 | 7.642M |
September 30, 2015 | 7.477M |
June 30, 2015 | 7.295M |
March 31, 2015 | 7.308M |
December 31, 2014 | 7.739M |
September 30, 2014 | 7.975M |
June 30, 2014 | 9.646M |
March 31, 2014 | 9.391M |
December 31, 2013 | 9.333M |
September 30, 2013 | 9.415M |
June 30, 2013 | 8.14M |
March 31, 2013 | 8.162M |
December 31, 2012 | 8.190M |
September 30, 2012 | 7.810M |
June 30, 2012 | 7.654M |
March 31, 2012 | 7.433M |
December 31, 2011 | 9.010M |
September 30, 2011 | 7.304M |
June 30, 2011 | 7.601M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.277M
Minimum
Mar 2023
9.112M
Maximum
Dec 2019
6.875M
Average
6.576M
Median
Total Liabilities (Quarterly) Benchmarks
AIM ImmunoTech Inc | 11.36M |
Perspective Therapeutics Inc | 48.40M |
Protalix BioTherapeutics Inc | 60.04M |
Electromed Inc | 6.357M |
Armata Pharmaceuticals Inc | 176.87M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.667M |
Shareholders Equity (Quarterly) | 1.162M |